Arbutus Biopharma Corp (NASDAQ:ABUS)

2.05
Delayed Data
As of Jun 05
 +0.01 / +0.49%
Today’s Change
0.82
Today|||52-Week Range
3.66
-26.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$149.6M

Company Description

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.

Contact Information

Arbutus Biopharma Corp.
701 Veterans Circle
Warminster Pennsylvania 18974
P:(267) 469-0914
Investor Relations:

Employees

Shareholders

Mutual fund holders4.94%
Other institutional33.71%
Individual stakeholders29.21%

Top Executives

There are no executives to display.